| Literature DB >> 15650773 |
Damani A Piggott1, Stephanie C Eisenbarth, Lan Xu, Stephanie L Constant, James W Huleatt, Christina A Herrick, Kim Bottomly.
Abstract
MyD88 is a common Toll-like receptor (TLR) adaptor molecule found to be essential for induction of adaptive Th1 immunity. Conversely, innate control of adaptive Th2 immunity has been shown to occur in a MyD88-independent manner. In this study, we show that MyD88 is an essential innate component in the induction of TLR4-dependent Th2 responses to intranasal antigen; thus we demonstrate what we believe to be a novel role for MyD88 in pulmonary Th2 immunity. Induction of the MyD88-independent type I IFN response to LPS is defective in the pulmonary environment. Moreover, in the absence of MyD88, LPS-induced upregulation of costimulatory molecule expression on pulmonary DCs is defective, in contrast to what has been observed with bone marrow-derived DCs (BMDCs). Reconstitution of Th2 responses occurs upon adoptive pulmonary transfer of activated BMDCs to MyD88-deficient recipients. Furthermore, the dependence of Th2 responses on MyD88 is governed by the initial route of antigen exposure; this demonstrates what we believe are novel site-specific innate mechanisms for control of adaptive Th2 immunity.Entities:
Mesh:
Substances:
Year: 2005 PMID: 15650773 PMCID: PMC544038 DOI: 10.1172/JCI22462
Source DB: PubMed Journal: J Clin Invest ISSN: 0021-9738 Impact factor: 14.808